当前位置: 首页 >> 检索结果
141. Risk Factors for Abdominal Pain-Related Disorders of Gut-Brain Interaction in Adults and Children: A Systematic Review.
作者: Jasmine K Zia.;Adrienne Lenhart.;Pei-Lin Yang.;Margaret M Heitkemper.;Jason Baker.;Laurie Keefer.;Miguel Saps.;Callie Cuff.;Gregory Hungria.;Elizabeth J Videlock.;Lin Chang.
来源: Gastroenterology. 2022年163卷4期995-1023.e3页
Many studies have assessed risk factors of irritable bowel syndrome (IBS) and other abdominal pain-related disorders of gut-brain interaction (AP-DGBI); however, the role of these factors is unclear due to heterogeneous study designs. The aim of this systematic review was to extensively evaluate the literature and determine clinical risk and protective factors for the presence and persistence of AP-DGBI in children and adults.
142. Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
作者: Laurent Peyrin-Biroulet.;Perttu Arkkila.;Alessandro Armuzzi.;Silvio Danese.;Jordi Guardiola.;Jørgen Jahnsen.;Charles Lees.;Edouard Louis.;Milan Lukáš.;Walter Reinisch.;Xavier Roblin.;Minyoung Jang.;Han Geul Byun.;Dong-Hyeon Kim.;Sung Jeong Lee.;Raja Atreya.
来源: BMC Gastroenterol. 2022年22卷1期291页
There are limited comparative data for infliximab and vedolizumab in inflammatory bowel disease patients.
143. Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses.
作者: Daniele Piovani.;Cesare Hassan.;Alessandro Repici.;Lorenza Rimassa.;Carmelo Carlo-Stella.;Georgios K Nikolopoulos.;Elio Riboli.;Stefanos Bonovas.
来源: Gastroenterology. 2022年163卷3期671-684页
To summarize the epidemiologic evidence and assess the validity of claimed associations of inflammatory bowel diseases (IBDs) with overall and site-specific cancer risk.
144. Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature.
作者: Hao Feng.;Linfeng Zou.;Xiao Zhai.;Shengyu Zhang.;Jingnan Li.
来源: BMC Gastroenterol. 2022年22卷1期246页
Intestinal lymphangiectasia (IL) is a rare disease characterized by dilation of lymphatic vessels and leakage of lymphatic fluids into the intestinal lumen, causing depletion of lymphocytes, protein, lipids, fat-soluble vitamins, and electrolytes. Hypomagnesemia can occur in IL patients but is seldom discussed.
145. The diagnostic utility of endocytoscopy for the detection of gastric cancer: a systematic review and meta-analysis.
作者: Andrew Canakis.;Shivanand Bomman.;Benjamin Twery.;Nevin Varghese.;Byung Ji.;Justin Canakis.;Eric M Goldberg.
来源: Minerva Gastroenterol (Torino). 2024年70卷2期225-230页
Endocytoscopy (ECS) is an evolving technology that utilizes ultra-high power magnification for real time cellular imaging without the need for physical biopsy. Its application for gastric cancer (GC) detection is not well evaluated at the current time, but there is potential that ECS can make a real time histopathological diagnosis to differentiate neoplastic from benign lesions. We aimed to investigate the diagnostic utility of ECS for GC detection.
146. The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis.
作者: Fiona A Ross.;James H Park.;David Mansouri.;Emilie Combet.;Paul G Horgan.;Donald C McMillan.;Campbell S D Roxburgh.
来源: BMC Gastroenterol. 2022年22卷1期176页
The presence of inflammation is a key hallmark of cancer and, plays an important role in disease progression and survival in colorectal cancer (CRC). Calprotectin detected in the faeces is a sensitive measure of colonic inflammation. The role of FC as a diagnostic test that may categorise patients by risk of neoplasia is poorly defined. This systematic review and meta-analysis aims to characterise the relationship between elevations of FC and colorectal neoplasia.
147. Sleeve gastrectomy versus Roux-en-Y Gastric Bypass for remission of type 2 diabetes mellitus at 1, 3 and 5 years: a systematic review and meta-analysis.
作者: Kaneez Fatima.;Sabeeh K Farooqui.;Izma Ajaz.;Shaikh T Ali.;Nida Hashmi.;Sara Nadeem.;Sameed A Ghazi.;Shahzeb H Kaleem.;Fatima S Bozdar.;Mushk Noorani.
来源: Minerva Gastroenterol (Torino). 2022年68卷4期450-458页
Sleeve gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB) are the two procedures used in the management of patient with obesity and type 2 diabetes mellitus (T2DM); however, it is still unclear which of the two is more efficient in the remission of type-2 diabetes mellitus.
148. Are gastrointestinal symptoms associated with higher risk of Mortality in COVID-19 patients? A systematic review and meta-analysis.
Gastrointestinal symptoms have been reported in patients with COVID-19. Several clinical investigations suggested that gastrointestinal symptoms were associated with disease severity of COVID-19. However, the relevance of gastrointestinal symptoms and mortality of COVID-19 remains largely unknown. We aim to investigate the relationship between gastrointestinal symptoms and COVID-19 mortality.
149. Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis.
作者: Angelo Viscido.;Marco Valvano.;Gianpiero Stefanelli.;Annalisa Capannolo.;Chiara Castellini.;Eugenia Onori.;Antonio Ciccone.;Filippo Vernia.;Giovanni Latella.
来源: BMC Gastroenterol. 2022年22卷1期92页
Mucosal healing (MH) evaluated by endoscopy is a novel target of therapy in UC as it is associated with improved long-term outcomes. It is defined based on the Mayo endoscopic score (MES), but it is still to define whether a value of MES 0 or 1 should be the target. The purpose of this paper is to present the results of a systematic review with meta-analysis which compares long-term outcomes of patients in steroid-free clinical remission with MES 0 with those with MES 1.
150. A Systematic Review and Meta-analysis of Dietary Interventions Modulating Gut Microbiota and Cardiometabolic Diseases-Striving for New Standards in Microbiome Studies.
作者: Ilias Attaye.;Moritz V Warmbrunn.;Aureline N A F Boot.;Suze C van der Wolk.;Barbara A Hutten.;Joost G Daams.;Hilde Herrema.;Max Nieuwdorp.
来源: Gastroenterology. 2022年162卷7期1911-1932页
Cardiometabolic diseases (CMDs) have shared properties and causes. Insulin resistance is a risk factor and characteristic of CMDs and has been suggested to be modulated by plasma metabolites derived from gut microbiota (GM). Because diet is among the most important modulators of GM, we performed a systematic review of the literature to assess whether CMDs can be modulated via dietary interventions targeting the GM.
151. A systematic review of the patient burden of Crohn's disease-related rectovaginal and anovaginal fistulas.
作者: Kristy Iglay.;Dimitri Bennett.;Michael D Kappelman.;Sydney Thai.;Molly Aldridge.;Chitra Karki.;Suzanne F Cook.
来源: BMC Gastroenterol. 2022年22卷1期36页
Crohn's disease (CD)-related rectovaginal fistulas (RVFs) and anovaginal fistulas (AVFs) are rare, debilitating conditions that present a substantial disease and treatment burden for women. This systematic literature review (SLR) assessed the burden of Crohn's-related RVF and AVF, summarizing evidence from observational studies and highlighting knowledge gaps.
152. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review.
作者: M Ellen Kuenzig.;Stephen G Fung.;Luba Marderfeld.;Joyce W Y Mak.;Gilaad G Kaplan.;Siew C Ng.;David C Wilson.;Fiona Cameron.;Paul Henderson.;Paulo G Kotze.;Jasmine Bhatti.;Vixey Fang.;Samantha Gerber.;Evelyne Guay.;Supun Kotteduwa Jayawarden.;Leo Kadota.;Fernando Maldonado D.;Jessica Amankwah Osei.;Ryan Sandarage.;Amanda Stanton.;Melissa Wan.; .;Eric I Benchimol.
来源: Gastroenterology. 2022年162卷4期1147-1159.e4页
The incidence of inflammatory bowel disease (IBD) is increasing internationally, particularly in nations with historically low rates. Previous reports of the epidemiology of pediatric-onset IBD identified a paucity of data. We systematically reviewed the global trends in incidence and prevalence of IBD diagnosed in individuals <21 years old over the first 2 decades of the 21st century.
153. Clinical and Endoscopic Characteristics Associated With Post-Endoscopy Upper Gastrointestinal Cancers: A Systematic Review and Meta-analysis.
作者: Leo Alexandre.;Theo Tsilegeridis-Legeris.;Stephen Lam.
来源: Gastroenterology. 2022年162卷4期1123-1135页
Ten percent of patients with an upper gastrointestinal cancer will have received an esophagogastroduodenoscopy (EGD) within 3 years before diagnosis, termed post-endoscopy upper gastrointestinal cancers (PEUGIC). We aimed to determine the characteristics of PEUGIC, and compare these with detected cancers.
154. Is it time to rethink the burden of non-coeliac gluten sensitivity? A systematic review.
作者: Federica Borrelli DE Andreis.;Annalisa Schiepatti.;Giulia Gibiino.;Carlo Fabbri.;Paola Baiardi.;Federico Biagi.
来源: Minerva Gastroenterol (Torino). 2022年68卷4期442-449页
Non-coeliac gluten sensitivity (NCGS) is still a poorly defined clinical condition. This review aims to describe the clinical features of subjects with a symptomatic response to gluten intake, and to estimate the prevalence of NCGS.
155. The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic review.
作者: Jie Chen.;Xuejie Chen.;Yuhao Sun.;Ying Xie.;Xiaoyan Wang.;Ran Li.;Therese Hesketh.
来源: BMC Gastroenterol. 2021年21卷1期469页
Cognitive behavioral therapy (CBT) is now included in the treatment of patients with inflammatory bowel disease (IBD) in many settings. However, different clinical trials report different outcomes without consensus. This study aims to evaluate the impact of CBT on the mental state, quality of life and disease activity of patients with IBD.
156. Helicobacter pylori infection is associated with reduced risk of Barrett's esophagus: a meta-analysis and systematic review.
Helicobacter pylori (Hp) is a class I carcinogen in gastric carcinogenesis, but its role in Barrett's esophagus (BE) is unknown. Therefore, we aimed to explore the possible relationship.
157. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis.
作者: Ankit Chhoda.;Ziga Vodusek.;Kapil Wattamwar.;Eric Mukherjee.;Craig Gunderson.;Alyssa Grimshaw.;Anup Sharma.;Nita Ahuja.;Fay Kastrinos.;James J Farrell.
来源: Gastroenterology. 2022年162卷3期786-798页
Identification and resection of successful targets, that is, T1 N0M0 pancreatic ductal adenocarcinoma (PDAC) and high-grade precursors during surveillance of high-risk individuals (HRIs) confers improved survival. Late-stage PDACs refer to T2-4 N0M0 and nodal or distant metastatic PDAC stages diagnosed during the follow-up phase of HRI surveillance. This study aimed to quantify late-stage PDACs during HRI surveillance and identify associated clinicoradiologic factors.
158. Clinicopathological significance of HSP70 expression in gastric cancer: a systematic review and meta-analysis.
Heat shock protein 70 (HSP70) has been associated with the clinicopathological characteristics and prognosis of many cancers types, implying that it is a potential cancer biomarker. However, no consensus has been reached regarding its clinicopathological and prognostic significance in patients with gastric cancer. To address this gap, we performed a systematic review and meta-analysis.
159. Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials.
作者: Shomron Ben-Horin.;Lena Novack.;Ren Mao.;Jing Guo.;Yue Zhao.;Ruslan Sergienko.;Jian Zhang.;Taku Kobayashi.;Toshifumi Hibi.;Yehuda Chowers.;Laurent Peyrin-Biroulet.;Jean Frederic Colombel.;Gilaad G Kaplan.;Min-Hu Chen.
来源: Gastroenterology. 2022年162卷2期482-494页
Starting biologic treatment early in the course of inflammatory bowel disease (IBD) may be associated with higher efficacy, especially in Crohn's disease (CD).
160. Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.
Patients with immune-mediated inflammatory diseases (IMIDs) have an increased risk of coronavirus disease 2019 (COVID-19), primarily attributed to the use of immunosuppressive drugs such as glucocorticoids, which may attenuate the response to vaccines. This meta-analysis assessed the serologic response to COVID-19 vaccination in patients with IMIDs.
|